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Background: In 2008 UK legislation was amended to enable the use of deferred consent for paediatric emergency
care (EC) trials in recognition of the practical and ethical difficulties of obtaining prospective consent in an
emergency situation. However, ambiguity about how to make deferred consent acceptable to parents, children and
practitioners remains. In particular, little is known about practitioners’ views and experiences of seeking deferred
consent in this setting.
Methods: As part of a wider study investigating consent methods in paediatric emergency care trials (called
CONNECT), a 20 item online questionnaire was sent by email inviting practitioners (doctors and nurses) who were
involved in talking with families about children’s and young people’s (aged 0–16 years) participation in UK EC trials.
To ensure those with and without experience of deferred consent were included, practitioners were sampled using
a combination of purposive and snowball sampling methods. Simple descriptive statistics were used to analyse the
quantitative data, whilst the constant comparative method was used to analyse qualitative data. Elements of a
symbiotic empirical ethics approach was used to integrate empirical evidence and bioethical literature to explore
the data and draw practice orientated conclusions.
Results: Views on deferred consent differed depending upon whether or not practitioners were experienced in this
consent method. Practitioners who had no experience of deferred consent reported negative perceptions of this
consent method; these practitioners were concerned about the impact that deferred consent would have upon the
parent-practitioner relationship. In contrast, practitioners experienced in deferred consent described how families
had been receptive to the consent method, if conducted sensitively and in a time appropriate manner. Experienced
practitioners also described how deferred consent had improved recruitment, parental decision-making capacity
and parent-practitioner relationships in the emergency care setting.
Conclusions: The views of practitioners with first-hand experience of deferred consent should be considered in the
design and ethical review of future paediatric EC trials; the design and ethical review of such trials should not solely
be informed by the beliefs of those without experience of using deferred consent. Further research involving par-
ents and children is required to inform practitioner training and normative guidance on the use and appropriate-
ness of deferred consent in emergency settings.* Correspondence: K.Woolfall@liverpool.ac.uk
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Clinical trials of interventions to save the lives of critic-
ally ill children are vital. However, recruitment to clinical
trials in the emergency care (EC) setting is fraught with
practical and ethical dilemmas. Children cannot legally
provide consent for their own participation in a clinical
trial; instead consent is sought from a parent or legal
guardian in addition to child assent [1,2]. Prior written
consent may not be logistically possible as parents are
not always present when a child enters hospital, or a
newly delivered mother maybe heavily sedated prevent-
ing prior consent for a newborn to enter a study. In cir-
cumstances where parents are present the therapeutic
window for successful intervention may be too short to
seek informed consent [3], or parents may lack the cap-
acity to provide adequately informed consent when their
child is critically ill [4]. The EC setting is time con-
strained and intensely emotional, posing ethical difficul-
ties for practitioners (doctors and nurses) recruiting to
clinical trials in ensuring that parental consent is in-
formed, participation is voluntary and the recruitment
process adheres to bioethical principles that govern re-
search ethics and underpin good professional practice,
such as respect for autonomy, justice, nonmaleficence
and beneficence [5,6].
Empirical research has indicated that practitioners are
anxious about approaching parents for consent to clin-
ical trials even outside of the emergency setting [7].
Seeking informed consent from parents in the emer-
gency setting has been regarded as needlessly cruel,
compromising individual autonomy and violating the
principle of beneficence [3,6-8]. The ethical validity and
practical feasibility of obtaining informed consent in this
setting has also been questioned [9]. To address these
complexities, one proposal is that an initial assessment
is undertaken to establish parents’ competence to under-
stand trial information and to evaluate capacity to pro-
vide informed consent [8,10]. Consent prior to a child’s
entry into a trial would only be sought if a parent was
deemed to be competent. This proposal includes a for-
mal assessment stage including the use of outcome as-
sessment tools, which are not commonly used in
conventional approaches to consent [10]. Alternatively a
staged (continuous consent) approach has been pro-
posed, which involves brief information provision prior
to randomisation followed by retrospective consent [11].
However, parental capacity to process brief information
provision and complete an assessment in this setting
may be questioned. Even brief information provision
could inappropriately burden parents when they are
highly stressed. It could also delay the treatment of a
critically ill child, particularly if parents have questions
about the trial. Waived and deferred consent methods,
whereby research can proceed without prospectiveconsent, have been proposed as potential solutions to
such difficulties [10].
Research without prospective consent prevents the
need to provide parents with information and burden
them with a request for decision making at a time when
their child’s condition is in the most critical stage. Some
have argued that deferring or waiving consent enables
vital research to proceed that benefits society as a whole
and avoids potentially harmful delays to the individual in
receiving the medical intervention [12,13]. However,
conducting research without prior consent has been sub-
ject to much debate. It poses a key ethical dilemma as
this approach prevents personal choice and therefore
erodes individual autonomy [14-16]. Consent for paedi-
atric clinical trials is sought from parents rather than
children [17] and in such trials it could be argued that
deferred consent is a further detraction from the patient
autonomy principle. As children (and parents in trials
that use deferred consent) have no control over whether
interventions are administered deferred consent may
also compromise rights based justice and the require-
ment to act in a fair manner [18]. Equity may also be
compromised if vulnerable groups, such as bereaved par-
ents, find it particularly difficult to understand trial in-
formation and make a consent decision due to
situational incapacity at the point when deferred consent
is sought [19]. However, others have argued that because
practitioners prescribe untested or unlicensed treat-
ments on a daily basis, distributive justice should be the
overriding principle to ensure that all children benefit
from evidence based treatments in the future [13,18]. In
United States of America and some parts of Europe, re-
search without consent is permitted in emergency set-
tings where the research is perceived to be of minimal
risk to participants. Practitioners are required to consult
with representatives of the patient community and post
public notices of the study protocol, risks, benefits and
results. How such consultation is implemented appears
to vary across studies. Some approaches are similar to
deferred consent [20,21], as practitioners often (but not
always) approach families with information at a later
stage when the situation is no longer critical and provi-
sions are made so that patients (or parents of children)
can ‘opt out’ of the trial if they wish [22,23]. Clinical re-
search is governed by European Community Directives
(2001/20/EC and 2005/28/EC) which set the legal frame-
work [24] for valid informed consent as the cornerstone
of experimental research involving human beings. How-
ever, these Directives made no provision for consent in
emergency situations, thus creating a barrier to research
in this setting [25].. However, in 2006, UK legislation
was amended to incorporate deferred consent in emer-
gency situations for adults [26], and this extended to
children in 2008 [27].
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inson (1980) and involves enrolling a patient to a trial
then seeking consent (from patients if they have capacity
or alternatively a surrogate decision maker) after enrol-
ment and administration of trial treatments in order for
the patient to continue in the trial [28]. Community
consultation is not required and consent is sought for
permission to use data that have already been collected.
It has been argued deferred consent addresses many of
the difficulties which compromise autonomous decision
making in the emergency setting, such as constraints on
time and parental capacity [11]. However, some have ar-
gued that deferred consent is ethically unsound and rep-
resents a dishonest attempt to justify recruitment
without consent [11,29]. It has been proposed that de-
ferred consent compromises the core value of informed
consent and that it is the role of ethicists to ensure that
informed decision making is defended [29]. A critical
issue as noted above is that by deferring consent seeking,
a patient is being asked to consent for the use of data
that has already been collected, or to consent to con-
tinue in the study, rather than for giving permission to
be entered into the study in the first place, which is ar-
gued to be the key function of consent in medical re-
search [30].
Despite these criticisms, deferred consent can be used
in UK clinical trials, although ambiguity about how to
make it practically and ethically acceptable to parents,
children and practitioners remains. In particular, little is
known about practitioners’ views and experiences of
seeking deferred consent in this setting [4,15]. Do they
have anxieties about deferring consent? What are their
perceptions of this method? And what are their experi-
ences of how parents react to finding out their child has
been entered into a trial? A key concern is that if the de-
cision to provide consent is associated with the outcome
then the trial results will be biased. And what happens if
a child dies before consent is sought? Excluding de-
ceased patients could lead to bias [31]. However, is it
ethically appropriate to approach bereaved parents? Em-
pirical research is required to help address these and
other key ethical questions to inform future clinical
practice in this setting, such as: does deferred consent
reduce individual autonomy? Does it compromise paren-
tal trust in the medical profession and negatively impact
upon immediate parent-practitioner relationship? Or can
deferred consent promote beneficence by supporting
situational capacity to provide informed consent at a
later stage when children are critically ill? [32].
To begin to answer these questions, this paper draws
on insights from empirical data from an online survey
on the views and experiences of clinical trial practi-
tioners working in paediatric and neonatal emergency
care settings. We purposively sampled practitioners toinclude those with experience of using deferred consent
and those who had not previously used this method of
consenting.Methods
Questionnaire
The findings we report here are part of a wider study,
CONNECT (CONseNt methods in paediatric Emer-
gency and urgent Care Trials). CONNECT is a mixed
method study involving parents, children and practi-
tioners from across the UK with experience of paediatric
EC. It will generate new evidence to help improve how
consent is sought for paediatric clinical trials in emer-
gency situations. Findings presented in this paper are de-
rived from the first stage of CONNECT; further findings
will be published in due course.
We designed a 20 item semi-structured questionnaire
(See Additional file 1) to examine the experiences and
attitudes of practitioners (doctors and nurses) involved
in recruiting to clinical trials in the EC setting. We de-
rived closed and open-ended questions from key issues
identified in the EC and ethics literature on consent
methods. Part A of the questionnaire contained ques-
tions on practitioners’ job description, experience and
trial specific questions, including: the types of consent
methods used in UK EC paediatric clinical trials (e.g.
proxy, deferred, prospective, child assent); how the con-
sent process is conducted and by whom; trial recruit-
ment and consent materials (including the involvement
of public and patient [PPI] representatives who are not
trial participants but contribute to the research team).
Part B contained questions to explore practitioners’
opinions on perceived barriers and facilitators to obtain-
ing patient and proxy consent/assent; perceived impact
of the trial recruitment and consent processes upon the
patient-investigator relationship; and training and sup-
port needs. The questionnaire was designed so that par-
ticipants could report on more than one trial by
completing multiple Part As. Opinion and training ques-
tions in Part B were only answered once by each
participant.
The questionnaire was reviewed by an expert advisory
panel established to inform the design and conduct of
CONNECT (n = 11) including: bio medical ethicists (n
= 3); medical sociologists (n = 2); statisticians (n = 2); a
health psychologist; a clinical trials manager; a patient
and public involvement representative; and a paediatric
intensive care research nurse. The questionnaire was
firstly piloted in one North West Clinical Trials Unit (n
= 7 questionnaires) with amendments made prior to dis-
semination. The study was approved by a UK National
Health Service ethics committee (Northwest- Liverpool
East Research Ethics Committee: 12/NW/0094).
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The questionnaire was sent by email invitation to practi-
tioners involved in talking with families about children’s
and young people’s (aged 0–16 years) participation in
UK EC trials. Each questionnaire was accompanied by a
letter outlining the aims of the study and providing in-
structions on how to complete the online questionnaire.
A participant information sheet was also attached which
provided further details of the study, including confiden-
tiality and data protection statements. Recruitment in-
volved purposive sampling to help ensure both research
nurses and doctors, as well as those with and without
experience of deferred consent were included in the
sample [33]. Snowball sampling was also used to access
clinical trial recruiters whose details were not accessible
to the researcher [9,34]. This involved distributing the
questionnaire via an email link to all trial managers and
clinical trial recruiters engaged in paediatric and neo-
natal emergency care trials through identified gate-
keepers in each of the 42 UK clinical trial units and
eight Medicines for Children Research Network
(MCRN) Local Research Networks (LRN). In addition,
KW contacted practitioners who were known to be
recruiting to trials in this setting through (MCRN) Clin-
ical Trials Unit (CTU) contacts. In order to access prac-
titioners who had experience of deferred consent the
questionnaire was also distributed to practitioners who
were actively recruiting to the CATCH trial at the time
that this survey was conducted. CATCH was a multi-
centre UK trial that incorporated a deferred consent
process to investigate interventions to reduce central
venous catheter-associated infections in children [35].
For CONNECT, practitioners were asked to complete
questionnaires for each paediatric emergency care trial
they had been involved in since 2004. This date was used
to identify consent methods used in trials conducted be-
fore and after the 2008 Medicines for Human Use (Clin-
ical Trials) regulations, which incorporated deferred
consent in paediatric emergency settings [24,27]. Snow-
ball sampling helped boost the size and diversity of the
sample; however this meant that response rates could
not be calculated as the total population who received
the questionnaire was not known [9,34]. Completion of
the questionnaire was taken as an indication of consent.
No identifiable personal data was collected.
Analysis
Quantitative data from closed questions were analysed
using simple descriptive statistics, chi-square test for
trend and Fisher Exact test as appropriate. QSR NVivo 9
software was used to assist in the organisation and
indexing of responses to open ended questions. Whilst
analysis was informed by the constant comparison ap-
proach of grounded theory, the focus was modified to fitwith the criterion of catalytic validity, whereby findings
should be relevant to future research and practice
[36,37]. Elements of a symbiotic empirical ethics ap-
proach was used to integrate empirical evidence and bio-
ethical literature [38], explore the data and draw practice
orientated conclusions. This included considering the
data in relation to the circumstances which impact upon
trial recruitment in this setting, and considering how
key theories and principles could inform the analysis
[38]. KW (a sociologist) led the analysis and develop-
ment of coding framework with assistance from BY (a
health psychologist) and LF (a bioethicist) to enable in-
vestigator triangulation [39]. The experience of practi-
tioners (e.g. experienced or not experienced in deferred
consent) is shown next to quotations presented in the
results section.
Results
Participant characteristics
In total, 45 EC practitioners completed the online ques-
tionnaire. The sample comprised 16 (36%) consultant
grade doctors and 29 (64%) research nurses. 39 (86.7%)
worked in paediatric emergency care units and n = 6
(13.3%) worked in neonatal intensive care units.. Six
(21%) of the research nurses were senior nurses. Twenty
five (56%) practitioners had been involved in delivering a
medical intervention in the context of any trial. Out of
the 45 participants, the average number of trials they
had recruited to was three (SD = 2.33), ranging from a
minimum of one trial (n = 12, 27%) to a maximum of
ten trials (n = 3, 7%). All participants provided at least
one response to an open ended question. There were
222 open ended responses in total.
Thirty-eight practitioners completed one Part A
(which contained trial specific questions) and seven
completed more than one Part A relating to more than
one trial. Three, two and two practitioners completed
two, three, and four part As respectively for their in-
volvement in multiple trials giving a total of 58 Part As
completed (mean = 1.28 completed per participant,
range 1–4). Opinion questions in Part B were only an-
swered once by each participant (n = 45). Data were col-
lected on 13 emergency and urgent care trials conducted
since 2004. Five trials began between 2004 and 2008
(one in each year), whilst three started in 2009, four in
2010 and one in 2011. The majority (n = 9/13, 69%)
began after UK legislation was amended in 2008 which
enabled the use of deferred consent in paediatric emer-
gency care trials [27].
In eight of the 13 (62%) trials, multiple types of con-
sent methods were used, reflecting complex study de-
signs (e.g. use of elective and emergency care arms
within the same trial). Practitioners in all 13 trials sought
prospective informed proxy consent from parents.
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up until (not including) 16 years of age. Deferred con-
sent was used in the emergency arm of only one trial
(CATCH), which (where appropriate) involved brief in-
formation provision prior to randomisation, followed by
full information and deferred consent within an optimal
48 hours of randomisation. The TOBY trial [40] (which
investigated whole body hypothermia for perinatal as-
phyxia) involved stages of consent (e.g. brief information
followed by full information provision) although full in-
formed consent was sought from all parents prior to en-
rolment and randomisation. Informed prospective assent
was sought from children in four trials, all were urgent
elective care trials (<16 years). Procedures for deferred
assent from children were reported in two emergency
care trials (CATCH and TOBY), whereby assent could
be sought when a child’s condition had been stabilized
and capacity to assent had returned. Nine practitioners
from four trials where the protocol required brief writ-
ten information to be provided to parents stated that
they had deviated from the consent model outlined in
the trial protocol. Open response comments at end of
the questionnaire suggested that this was due to parents
not being present in order to receive trial information.
Over half the sample (n = 27/45, 60%) of practitioners
had experience of using deferred consent in an emer-
gency or urgent care trial. As CATCH was the only trial
identified by this survey as having used deferred consent,
it is likely that the rest of the sample did not have the
opportunity to use this consent method. Due to the sam-
pling strategy used, a large proportion of part A ques-
tionnaires (n = 26/58, 45%) reported on the CATCH
trial. The findings are presented under the key themes
derived from the synthesis of qualitative and quantitative
data analyses.
Consent in the emergency context
Practitioners were asked to rate (from very well, to not
at all well) how well they felt parents or family members
understood the trial information provided in an emer-
gency/urgent care situation. Just over half (n = 26/45,
58%) responded that parents understood the information
well (n = 25/45, 56%), or very well (n = 1/45, 2%). Ap-
proximately a third (n = 14/45, 31%) were unsure. FewTable 1 How well do you feel parents/family members unders
emergency/urgent care situation? (n = 45)
Very well Well
Experienced in deferred consent 1 (4) 14 (52)
Not experienced in deferred consent 0 (0) 11 (61)
Consultant 1 (6) 8 (50)
Research Nurse 0 (1) 17 (58)
Figures are n (%), percentages are rounded to one decimal place.practitioners indicated that parents did not understand
the information well (n = 4/45, 9%), or not at all well
(n = 1/45, 1%). As shown in Table 1, there were no sta-
tistically significant differences between groups in their
perceptions of perceived parental/family member under-
standing of trial information in an emergency situation
by experience of deferred consent or job type (consult-
ant or research nurse).
Some practitioners questioned parents’ ability to
provide informed consent in an emergency setting, par-
ticularly if consent was sought before prior to random-
isation: “I have been involved in many neonatal trials-
many of which are emergency. We generally obtain con-
sent before. It’s clear that people cannot be given FULLY
informed consent because of the high emotion and ur-
gency of the situation” (P44, not experienced in deferred
consent).
Some practitioners viewed recruitment in EC as being
an additional burden for parents, who they regarded as
being already highly anxious about their child, even
when consent was deferred “It [clinical trial recruitment]
increases the parent/carer stress levels dramatically (P20,
experienced in deferred consent). Such comments were
made by consultants and research nurses in the open
comments section at the end of the questionnaire, sug-
gesting that the impact of the emergency setting upon
parents’ ability to provide consent was an important
point which they wished to emphasise.Deferred consent and the parent-practitioner relationship
Practitioners were asked: ‘Do you think that approaching
a parent/family member for deferred consent for their
child’s participation in an emergency/urgent care trial
can have a negative impact upon the parent/family
member and practitioner relationship?’ Views were di-
vided, whereas 44.4% (n = 20/45) did not believe there
would be any negative impact, over half (n = 25/45,
55.5%) felt there could be either a small (defined as ‘A
little’) (n = 20/45, 44.1%) or a fair amount of negative
impact (n = 5/45, 11.1%). No practitioners indicated that
approaching parents for deferred consent would have
significant (‘A lot’) negative impact upon the parent-
practitioner relationship.tand the trial information given to them in an
Unsure Not well Not at all well p-value
10 (37) 2 (7) 0 (0) 0.52
4 (22) 2 (11) 1 (6)
5 (31) 1 (6) 1 (6) 0.41
9 (31) 3 (10) 0 (0)
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pact of deferred consent upon parent-practitioner rela-
tionship depending upon whether or not practitioners
had experience of using deferred consent (p = 0.01). As
shown in Table 2, a higher percentage of those who were
experienced in deferred consent (n = 16/27, 59%)
responded that the method would not negatively impact
upon the parent-practitioner relationship, compared to
those who had not previously used deferred consent (n
= 4/18, 22%).
There was no significant association between whether
a practitioner was involved in administering interven-
tions that were part of an EC clinical trial (p = 0.4) and
perceived impact of deferred consent on the parent-
practitioner relationship. Although not statistically sig-
nificant (p = 0.2) a higher percentage of nurses (n = 18/
29, 62%) stated that asking a parent for consent in EC
could have a negative impact upon the relationship with
parents and families when compared to consultants (n =
7/16, 43%).
In their free text responses experienced practitioners
reflected on how families were generally happy to be
approached after their child had been randomised:
“Nearly all families were openly receptive and wanted
their child to be involved” (P1, experienced in deferred
consent) or indicated how parental responses to deferred
consent in the emergency care setting had not been
problematic: “I have found that gaining deferred consent
has been straightforward overall” (P16, experienced in
deferred consent).
A tailored approach to recruitment
The emergency setting posed difficulties for clinical trial
recruitment. Nine practitioners (20%) from four trials
stated that they had deviated from the consent model
outlined in the trial protocol. Additional comments at
end of the questionnaire suggested that deviations oc-
curred when parents had not been present when a child
was receiving emergency treatment and therefore practi-
tioners had been unable to provide brief information
about the trial to parents. Practitioners commented onTable 2 Do you think that approaching a parent/family memb
an emergency/urgent care trial can have a negative impact u
relationship? (n = 45)
No (Not at all)
Experience in deferred consent 16 (59)
No experience in deferred consent 4 (22)
Consultant 9 (56)
Research nurse 11 (38)
Involved in administering interventions 13 (50)
Not involved in administering interventions 7 (37)
Figures are n (%), percentages are rounded to one decimal place.how parents were highly variable in their willingness to
engage in a recruitment discussion and make a decision
about trial entry when children are critically ill. There-
fore practitioners needed to gauge the preferences of in-
dividual families and tailor their approach accordingly:
“Some families can only think about and focus on their
child getting better. They don't want to have to read,
talk, as well as make a decision about research during
this time. However some families do and are positive
about research it’s a mix of people with different views
and you approach them and see how they respond. If
it’s negative, give them more time” (P27, experienced
in deferred consent).
Practitioners emphasised importance of appropriate
timing when initially approaching parents about a
trial. They wrote about how the deferred consent
method had enabled research nurses to approach
parents at a time when they were better able to
process information, in comparison to approaching
them when in the crisis of emergency treatment:
“When seeking deferred consent from parents we are
first of all doing it at a time when we believe the
parents can take in and process additional
information in a rational and reasoned manner” (P17,
experienced in deferred consent).
Recruitment and communication
Regardless of their experience of deferred consent, some
practitioners described how clinical trial recruitment
could strengthen relationships with patients, “Opens up
communication further” (P14, not experience in deferred
consent), mainly by helping to enhance communication
between parents and practitioners about research, “Often
the parents feel they are contributing to research in the
area which aids to conversation and communication gen-
erally between research nurse, clinical staff and the fam-
ily” (P36, experienced in deferred consent), or their
child’s condition and treatment: “It offers a chance for
more in depth discussion about the baby’s condition”
(P25, experienced in deferred consent).er for deferred consent for their child’s participation in
pon the parent/family member and practitioner
Yes (a little, a fair amount or a lot) p-value
11 (41) 0.01
14 (78)
7 (43) 0.24
18 (62)
13 (50) 0.38
12 (63)
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when broaching a clinical trial that involved deferred
consent. Practitioners wrote of how it was important to
clearly explain to parents why deferred consent was be-
ing used: “As long as the person introducing the trial and
taking consent is clear about why deferred consent is be-
ing used, all the parents I have spoken to have had no is-
sues” (P10, experienced in deferred consent) as well as
to clarify that any decisions parents made about clinical
trial entry would not impact upon the clinical care of
their child: “It is made clear that not taking part in the
study has NO bearing on their subsequent management
in the trials where informed consent required prior to ad-
ministration of trial substance” (P42, experienced in de-
ferred consent).
The appropriateness of deferred consent
Many of those who were experienced in deferred con-
sent reflected upon the method in the free comments
box. Some described how they felt that deferred consent
could be useful in clinical trial recruitment: “The use of
deferred consent within the emergency care setting is a
valuable tool, which should be considered more often”
(P10, experienced in deferred consent). Others described
how they felt the method was ethically sound: “I believe
there are absolutely no ethical issues with the framework
that is in place” (P45, experienced in deferred consent),
or how families had no concerns about recruitment tak-
ing place after the intervention: “No real concerns about
the fact that the intervention has already been done”
(P29, experienced in deferred consent).
In contrast, one practitioner described how some par-
ents felt that their voluntariness had been compromised
by their child’s entry into a trial without their prior con-
sent: “Some parents felt that the decision had been taken
out of their hands by the trial line (central venous cath-
eter) already being inserted” (P30, experienced in de-
ferred consent). Another clinician seemed to reflect
positively on how parents were unable to distinguish be-
tween research and standard care. This practitioner ap-
peared to focus primarily on how deferred consent
improved recruitment rates rather than its impact on
the quality of recruitment: “Deferred consent if appropri-
ate for that child/trial is really improves recruitment to
the clinical trials as the procedure has already occurred
and doesn’t seem as much as a deviation from standard
care to most families” (P36, experienced in deferred
consent).
Training and guidance
Although all practitioners sampled were experienced in
clinical trial recruitment, just over half (n = 25, 55.6%)
felt they would benefit from training to assist them in
discussing emergency/urgent care trials with familiesand obtaining consent. Their suggestions included: spe-
cialised training courses or workshops (n = 3); struc-
tured guidelines (n = 3), peer support, such as
shadowing experienced trial recruiters or an online
forum (n = 3), reading applicable research findings (n =
1), or openly accessible DVD or online materials (n = 1).
The need for guidance on seeking deferred consent with
bereaved parents was emphasised by two practitioners,
both of whom emphasised the complexities of ap-
proaching bereaved parents for consent and the need for
research to inform future practice:
“There needs to be a discussion on seeking deferred
consent from bereaved parents. When is the best time
to approach, where, by whom, how should it be done,
is it actually necessary?…does approaching these
parents cause added stress/upset/confusion/-knowing
how these parents feel would be very interesting
indeed. This really needs to be debated by those
involved in paediatric research” (P17 experienced in
deferred consent).
“Different options in the protocol for consent that
allows the practitioner to use their clinical judgement.
E.g. when a patient dies before the consent is signed
and although you have already approached the family
prior to this you feel that it would be inappropriate to
force them to make a decision when their child has
just died. If following the protocol you would need to
get an answer ideally within 48 hrs of randomisation.
This could have an extremely negative impact on the
family and influence their thoughts about
participating in research in the future” (P18
experienced in deferred consent).
Discussion
Deferred consent provides a means of addressing the
practical and ethical difficulties of obtaining prospective
consent in an emergency situation, thus enabling med-
ical research in children to precede that may benefit so-
ciety as a whole. Practitioners’ views on deferred consent
differed depending upon whether or not they were expe-
rienced in the deferred consent method. Negative per-
ceptions were held by those who had not used deferred
consent, particularly when responding to questions
about the impact of clinical trial recruitment upon the
parent-practitioner relationship. Those who had not
used deferred consent described how parents can have a
negative perception of EC clinical trials, which impacted
upon the parent-practitioner relationship by making
practitioners feel uncomfortable in interactions that took
place after approaching parents about a trial [7]. In con-
trast, those who had used deferred consent described
the positive impact that EC clinical trial recruitment can
have upon the parent-practitioner relationship. Such
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practitioners with first hand experience of deferred con-
sent should be considered in the design and ethical re-
view of future paediatric EC trials; the design and ethical
review of such trials should not solely be informed by
the beliefs of those without experience of using deferred
consent. These findings also highlight the importance of
conducting empirical research to inform debate around
key ethical problems [38,41].
Our findings support previous literature which out-
lines the practical and ethical complexities of seeking
consent in the EC setting [4,6]. Practitioners perceived
trial recruitment as an additional burden upon parents
who were already anxious about their sick child
[7,15,42]. Some questioned the ability of parents to
process trial information when they arrived at hospital;
particularly practitioners who had not used deferred
consent. These practitioners raised concerns about ap-
proaching families in an emergency situation and re-
ported that recruitment was a potential burden for
families who were situationally incapacitated [7,11]. Such
practitioners described how consent prior to randomisa-
tion could not be ‘fully’ informed as parents lacked cap-
acity to digest trial information and make an informed
decision about their child’s participation in a trial. These
accounts contrasted with to those who had used de-
ferred consent, who stated that this method enabled
them to approach families when they were able to ‘take
in and process’ trial information. Findings from practi-
tioners with experience of deferred consent suggest that
this consent method assists capacity to make informed
decision making in an emergency situation in ways that
the conventional approach of seeking of prior consent
cannot. Moreover, our findings raise questions about the
purpose of prior consent for EC trials as practitioners’
accounts indicate that this method cannot satisfy ethical
and clinical practice guidelines on informed consent
[6,24,30]. If parents are unable to digest information
about the nature, significance, implications and risks of
the study and make informed autonomous decisions,
then is it inappropriate to be placing such demands
upon them? Indeed, if they unable to process trial infor-
mation then prior consent becomes only an administra-
tive exercise to protect the legal interests and obligations
of the health provider rather than respecting key bio-
ethical principals such as respect for autonomy. The eth-
ical validity and feasibility of obtaining informed consent
or even providing brief information as part of a continu-
ous consent approach is therefore in doubt [11].
The importance of timing and experiential learning in
determining when is appropriate for practitioners to
broach a trial in emergency care settings was evident in
our findings. By deferring consent practitioners were
able to provide time for parents to consider the trialinformation and have the opportunity to ask questions,
as well as allowing practitioners to use their judgement
to gauge when was the best time to make the approach
[8]. A quarter of practitioners reported having to modify
the consent model defined in the trial protocol because
they were unable to provide brief prospective informa-
tion. This reflects the often complex and time con-
strained emergency care setting [4]. Parents were not
always available when a child was admitted, or there was
insufficient time to provide brief information prior to
randomisation. Brief information provision as part of a
staged approach to consent may therefore not be prac-
ticable in the paediatric emergency care setting. Such
observations are consistent with literature which has
shown how the multifaceted nature of clinical practice is
not always reflected in trial protocols, creating further
difficulties in seeking consent [43].
Deferred consent was valued by those experienced in
the approach. First-hand experience with deferred con-
sent appeared to dispel some of the anxieties about the
method. Indeed, almost all of those with experience of
the method supported the use of deferred consent [44]
and highlighted how it had enabled them to defer ap-
proaching parents about a trial to a time which was
more ethically appropriate, when parents were less
stressed and had improved capacity for informed deci-
sion making [11]. Such findings suggest that if con-
ducted sensitively, and in a time appropriate manner, the
deferred method can assist, rather than impede, parental
decision making. However, a concern raised by one prac-
titioner echoes that of some critics who state that volun-
tariness has already been compromised to some extent
by the intervention being administered prior to recruit-
ment [45]. Our findings raise questions about whether
deferred consent limits parental autonomy as the inter-
vention had already occurred [46]. The deferred consent
approach may result in trial information being provided
at a more appropriate time, when parents are more able
to process and provide informed decisions’, yet what par-
ents are consenting for has essentially been restricted.
After all, deferred consent in this situation is about per-
mission to continue in the study, or for use of data ob-
tained, rather than to take part in the study [2,11,30].
Critics have argued that if parents are present at the
time of recruitment and brief information is not pro-
vided, then deferred consent compromises individual au-
tonomy and does not comply with the clinical practice
guidelines on informed consent [11,24,30].
A further ethical issue was evident in comments made
by a practitioner who expressed the value of deferring
consent in terms of accrual rather than quality of re-
cruitment. Although high accrual to paediatric clinical
trials is important to inform future clinical practice, re-
cruitment rates should not take precedence over ethical
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quired on communication between practitioners and
parents in trial recruitment discussions to explore ques-
tion such as: how do practitioners describe deferred con-
sent to parents? And do they explain how a trial is
different from routine clinical practice? [48].
Practitioners’ responses could help to inform training
and guidance to inform the ethical conduct of this ap-
proach to seeking consent for UK clinical trials in emer-
gency and urgent care settings. Considered alongside the
wider literature, our study findings suggest this training
would benefit from a focus on the process of communi-
cating with families about a trial, the difference between
standard care and clinical trials, and the importance of
timing when approaching parents in this challenging set-
ting [29,48]. Training would also benefit from consider-
ation of which bioethical principles should inform
recruitment practice. Research is also necessary to ex-
plore the views of parents who have been approached
about EC trials to see if practitioners’ perceptions and
reports of families’ responses to the different consent
methods are echoed by families themselves.
Limitations and future research
Deferred consent was used in only one of the 13 trials
reported by this sample, which is likely to be due to the
relatively recent changes in UK legislation (2008) to de-
velop protocols using this method and the sample con-
taining trials from 2004 onwards [27]. However,
approximately half the study sample were experienced in
deferred consent and half were not, providing an oppor-
tunity to compare and contrast views. Our study reports
on a structured online survey, which limits the types of
insights that it can provide. Moreover, we only report on
the views of practitioners. The views of parents and chil-
dren may be very different to those of practitioners, and
as we note above, further work is needed to investigate
the views of family members who have been on the re-
ceiving end of deferred consent. In-depth qualitative
data will be collected in the next stages of the CON-
NECT study to explore the views and opinions of all
stakeholders in CATCH. As well as interviews with
recruiting practitioners, this will involve interviews with
children and parents, including bereaved parents , in
order to draw normative conclusions [49]. This study
was not powered to detect differences between the
groups. Due to the small sample size it is important that
absence of statistical significance is not interpreted as no
difference between the groups compared. Our sample
was also non random and we were unable to report re-
sponse rates so our findings should be interpreted with
caution.
While the use of purposive sampling helped to access
the views of practitioners who were experienced indeferred consent as well as those without such experi-
ence, it should be noted that all sampled practitioners
with experience of deferred consent were from the
CATCH trial. This is a low risk medical device trial [35].
Further research is required to explore clinician experi-
ences in differing trial types (e.g. drug trials, and trials
comparing less widely used treatments), if the deferred
consent method is to be utilised more widely in the fu-
ture. Research is also required to explore whether practi-
tioners’ ethical orientations impact on their views on the
acceptability and use of deferred consent in this setting.
Findings suggest that future protocols for clinical
trial recruitment in emergency care should acknow-
ledge the ethical implications of broaching a trial in
urgent or emergency care and outline how parents
should only be approached when it is judged by the
practitioner as being ethically viable to do so [50].
One solution may be to outline options within the
trial protocol to acknowledge practitioner’s personal
judgement and provide flexibility to protect families
in this setting. This could include options such as
stages of consent, including brief information
provision prior to randomisation if the practitioner
deems it to be appropriate. Further research is re-
quired to explore this proposal. Research is also re-
quired to establish whether and how bereaved
parents ought to be approached about a clinical trial.
Such research should focus on how consent pro-
cesses could avoid distressing such a vulnerable
group and provide recommendations for future re-
cruitment practice [19,51].Conclusions
The highly emotive and time limited emergency care
setting compromises parental capacity to provide in-
formed consent for their child’s participation in a
clinical trial. The views of practitioners experienced
in seeking deferred consent suggest that if conducted
sensitively, and in a time appropriate manor, defer-
ring consent can assist rather than impede autono-
mous decision making. However, evidence on the
views of children and parents, including parents
whose child has died after an emergency admission,
are vital to draw normative conclusions. Our find-
ings highlight how the views of practitioners with
first hand experience of deferred consent should be
incorporated into the design and ethical review of
future paediatric EC trials. Further research with
parents and practitioners is required to inform train-
ing and normative guidance to assist the ethical con-
duct of this relatively new approach to seeking
consent for UK clinical trials in emergency and ur-
gent care settings.
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